Clearance of hepatitis B surface antigen after bone marrow transplantation: Role of adoptive immunity transfer

Hepatology

Volumn 25, Issue 6, 1997, Pages 1497-1501

  Lau, George K K ^a   Lok, Anna S F ^b   Liang, Raymond H S ^a   Lai, Ching Lung ^a   Chiu, Edmond K W ^a   Lau, Lung Yu ^a   Lam, Shiu Kum ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADOPTIVE IMMUNOTHERAPY; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; CLEARANCE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; TREATMENT OUTCOME; VIRUS DETECTION;

ADOLESCENT; ADOPTIVE TRANSFER; ADULT; BONE MARROW; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; TISSUE DONORS; TREATMENT OUTCOME;

EID: 0031005299     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250631     Document Type: Article

References (29)

1. Wong DK, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993;15:119:312-323.
2. Carreno V, Castillo I, Molina J, Porres JC, Bartolome J. Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy. J Hepatol 1992;15:102-106.
3. Korenman J, Baker B, Waggoner J, Ecerhart JE, Di Bisceglie AM, Hoof-nagle JH. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med 1991;114:629-634.
4. Lok ASF, Wu PC, Lai CL, Lau JYN, Leung EKY, Wong LSK, Ma OCK, et al. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. Gastroenterology 1992;102:2091-2097.
5. Lok ASF, Chung HT, Liu VWS, Ma OCK. Long-term follow-up of chronic hepatitis B treated with interferon alpha. Gastroenterology 1993;105:1833-1838.
6. Cerny A, Ferrari C, Chisari FV. The class I-restricted cytotoxic T-lymphocyte response to predetermined epitopes in the hepatitis B and C viruses. Curr Top Microbiol Immunol 1994;189:169-186.
7. Rehermann B, Lau D, Hoofnagle JH, Chisari FV. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest 1996;97:1655-1665.
8. Shouval D, Adler R, Ilan Y. Adoptive transfer of immunity to hepatitis B virus in mice by BMT from immune donors. HEPATOLOGY 1993;17:955-959.
9. Ilan Y, Nagler A, Adler R, Naparstek E, Or R, Slavin S, Brautbar C, et al. Adoptive immunity transfer of immunity to hepatitis B virus after T cell depleted allogeneic BMT. HEPATOLOGY 1993;18:246-252.
10. Shouval D, Ilan Y. Transplantation of hepatitis B immune lymphocytes as means for adoptive transfer of immunity to hepatitis B virus. J Hepatol 1995;23:98-101.
11. Shouval D, Ilan Y. Immunization against hepatitis B through adoptive transfer of immunity. Intervirology 1995;38:41-46.
12. Lok ASF, Liang RH, Chung H. Recovery from chronic hepatitis B [Letter]. Ann-Intern Med 1992;116:957.
13. Ilan Y, Nagler A, Adler R, Tur-Kaspa R, Slavin S, Shouval D. Ablation of persistent hepatitis B by BMT from a hepatitis B immune donor. Gastroenterology 1993;104:1818-1821.
14. McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Venoocclusive disease of the liver after BMT: diagnosis, incidence and predisposing factors. HEPATOLOGY 1984;4:116-122.
15. Matsuyama Y, Omata M, Yokosuka O, Imazeki F, Ito Y, Okuda K. Discordance of hepatitis B e antigen/antibody and hepatitis B virus deoxyribonucleic acid in serum. Gastroenterology 1985;89:1104-1108.
16. Chung HT, Lok ASF, Lai CL. Re-evaluation of α-interferon-treatment of chronic hepatitis B using polymerase chain reaction. J Hepatol 1993;17:208-214.
17. Lau JYN, Davis GL, Kniffens J, Qian KP, Urdea MS, Chan CS, Masashi M, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993;341:1501-1504.
18. Liaw YF, Sheen IS, Chen TJ, Chu CM, Pao CC. Incidence, determinants and significance of delayed clearance of serum hepatitis B surface antigen in chronic hepatitis B virus infection: a prospective study. HEPATOLOGY 1991;13:627-631.
19. Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987;69:369-380.
20. Hoofnagle JH, Peters M, Mullen KD, Jones DB, Rustgi V, DiBisceglie AM, Hallahan C, et al. Randomised, controlled trial of recombinant human-interferon in patients with chronic hepatitis B. Gastroenterology 1988;95:1318-1325.
21. Lok ASF, Wu PC, Lai CL, Leung EK. Long-term follow-up in a randomised controlled trial of recombinant-interferon in Chinese patients with chronic hepatitis B-virus infection. Lancet 1988;2:298-302.
22. Alexander GJM, Brahm J, Fagen EA, Smith HM, Daniels HM, Eddleston ALWF, Williams R. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection. Lancet 1987;2:66-69.
23. Milich D. T- and B-cell recognition of hepatitis B viral antigens. Immunol Today 1988;9:380-388.
24. Lok ASF, Lai CL, Wu PC, Wong VCW, Yeoh EK, Lin HJ. Hepatitis B virus infection in Chinese families in Hong Kong. Am J Epidermiol 1987;126:492-499.
25. Guidotti LG, Ando K, Hobbs MV, Ishikawa T, Rundel L, Schreiber RD, Chisari FV. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci USA 1994;91:3764-3768.
26. Davis HL, Schirmberk R, Reimann J, Whalen RG. DNA-mediated immunization in mice induces a potent MHC-class-I-restricted cytotoxic T lymphocytes response to the hepatitis B envelope protein. Hum Gene Ther 1995;6:1447-1456.
27. Vitiello A, Ishioka G, Grey HM, Rose R, Farness P, LaFond R, Yuan L, et al. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. J Clin Invest 1995;95:341-349.
28. Ilan Y, Nagler A, Shouval D, Ackerstein R, Kapelushnik J, Adler R, Slavin S. Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immuned donors. Clin Exp Immunol 1994;97:299-302.
29. Cerny A, Fowler P, Brothers MA, Houghton M, Schlicht HJ, Chisari FV. Induction in vitro of a primary human antiviral cytotoxic T cell response. Eur J Immunol 1995;25:627-630.